Nurse Practitioner, Family · El Paso, TX
NPI
1952572166
Since 2008
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1700 Curie Dr Ste 4700
El Paso, TX, 79902
Phone (915) 532-1197
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$749K
10,590 prescriptions
Company payments, 2025
$1,913
From 11 companies
Medicare prescription drug claims, 2024
In 2024, the drug Vivian Villarreal prescribed most often to Medicare patients was Levothyroxine Sodium, with 528 prescriptions and refills. In total Vivian Villarreal wrote 10,590 Medicare prescriptions that cost $749K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Levothyroxine Sodium Generic | 528 | 534 | 27 | $8,127 |
| Atorvastatin Calcium Generic | 462 | 466 | 35 | $6,692 |
| Metformin Hcl Generic | 414 | 419 | 26 | $5,960 |
| Tamsulosin Hcl Generic | 387 | 387 | 22 | $5,994 |
| Gabapentin Generic | 337 | 337 | 23 | $5,093 |
| Amlodipine Besylate Generic | 324 | 324 | 22 | $4,577 |
| Losartan Potassium Generic | 291 | 293 | 14 | $4,281 |
| Memantine Hcl Generic | 276 | 276 | 22 | $5,135 |
| Rosuvastatin Calcium Generic | 272 | 272 | 17 | $4,106 |
| Lisinopril Generic | 267 | 267 | 23 | $3,864 |
| Famotidine Generic | 248 | 248 | 36 | $3,683 |
| Clopidogrel Clopidogrel Bisulfate | 229 | 229 | 15 | $3,429 |
| Duloxetine Hcl Generic | 197 | 197 | Under 11 | $5,448 |
| Icosapent Ethyl Generic | 192 | 192 | 14 | $15K |
| Eliquis Apixaban | 192 | 192 | 13 | $60K |
Brand drugs: 1,411 claims; generic drugs: 9,157 claims; opioid claims: 83.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Vivian Villarreal $1,913 ($1,913 in general payments such as food, travel and fees) from 11 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $361.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 3 | $361 |
| Novo Nordisk Inc NVO | 3 | $330 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $207 |
| Amgen Inc. AMGN | 1 | $146 |
| Dexcom, Inc. DXCM | 2 | $141 |
| Medtronic, Inc. MDT | 1 | $131 |
| Corcept Therapeutics CORT | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $122 |
| Genzyme Corporation SNY | 1 | $119 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.